Barclays’s Innate Pharma IPHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Hold |
307
| – | – | ﹤0.01% | 4297 |
|
|
2025
Q1 | $1K | Hold |
307
| – | – | ﹤0.01% | 4316 |
|
|
2024
Q4 | $1K | Hold |
307
| – | – | ﹤0.01% | 4327 |
|
|
2024
Q3 | $1K | Sell |
307
-105
| -25% | -$342 | ﹤0.01% | 4274 |
|
|
2024
Q2 | $1K | Hold |
412
| – | – | ﹤0.01% | 4137 |
|
|
2024
Q1 | $1K | Hold |
412
| – | – | ﹤0.01% | 4126 |
|
|
2023
Q4 | $1K | Hold |
412
| – | – | ﹤0.01% | 4155 |
|
|
2023
Q3 | $1K | Hold |
412
| – | – | ﹤0.01% | 4208 |
|
|
2023
Q2 | $1K | Hold |
412
| – | – | ﹤0.01% | 4188 |
|
|
2023
Q1 | $1K | Hold |
412
| – | – | ﹤0.01% | 4251 |
|
|
2022
Q4 | $2K | Buy |
412
+289
| +235% | +$1.4K | ﹤0.01% | 4291 |
|
|
2022
Q3 | $0 | Sell |
123
-2,056
| -94% | – | ﹤0.01% | 4733 |
|
|
2022
Q2 | $6K | Sell |
2,179
-1,232
| -36% | -$3.39K | ﹤0.01% | 4437 |
|
|
2022
Q1 | $11K | Buy |
+3,411
| New | +$11K | ﹤0.01% | 4468 |
|